The cardiovascular effects of equipotent concentrations of enflurane and halothane were studied and compared in two groups of patients. The agents were shown to have similar effects.
References
1.
BlochM. (1966): “Systemic Effects of Nitrous Oxide and Oxygen when Used with Halothane and Oxygen Anaesthesia at Normal Body Temperature”, Brit. J. Anaesth., 38, 119.
2.
BloodwellR. D., BrownR. C., ChristensenG. R., GoldbergL. I., and MorrowA. G. (1965): “The Effect of Fluothane on Myocardial Contractile Force in Man”, Anesth. Analg., 40, 352.
3.
BottyC., BrownB., StanleyV., and StephenC. R. (1968): “Clinical Experiences with Compound 347, a Halogenated Anesthetic Agent”, Anesth. Analg. (Curr. Res.), 47, 499–505.
4.
BylesP. H., DobkinA. B., FergusonJ. H., and LevyA. A. (1971): “Forane (Compound 469); Cross-Over Comparison with Enflurane, Halothane and Methoxyflurane in Dogs”, Canad. Anaesth. Soc. J., 18, 376–386.
5.
EgerE. I. H., SmithN. Ty., StockingR. K., CullenD. J., KadisL. B., and WhitcherC. E. (1970): “Cardiovascular Effects of Halothane in Man”, Anesthesiology, 32, 396.
6.
EgilmezA., and DobkinA. B. (1972): “Enflurane in Man”, Anaesthesia, 27, 171.
7.
EnderbyG. E. H. (1960): “Halothane and Hypotension”, Anaesthesia, 15, 25.
8.
IwatsukiN., ShimosatoS., and EtstenB. E. (1970): “The Effects of Changes in Time Interval of Stimulation on Mechanics of Isolated Heart Muscle and its Response to Ethrane”, Anesthesiology, 32, 11.
9.
McDowellS. A. (1968): “Difluoromethyl 1, 1, 2-Trifluoro–2–chloroethyl Ether; Experiments on Dogs”, Brit. J. Anaesth., 40, 511–516.
10.
MorrowD. H., and MorrowA. G. (1961): “The Effects of Halothane on Myocardial Contractile Force and Vascular Resistance; Direct Observations Made in Patients During Cardiopulmonary Bypass”, Anesthesiology, 22, 537.
11.
PayneJ. P., GardinerD., and VernerI. R. (1959): “Cardiac Output During Halothane Anesthesia”, Brit. J. Anaesth., 31, 87.
12.
PriceH. L., and HelrichM. (1955): “The Effect of Cyclopropane, Dyethyl Ether, Nitrous Oxide, Thiopental, and Hydrogen Ion Concentration on the Myocardial Function of the Dog Heart-lung Preparation”, J. Pharm. exp. Ther., 115, 206.
13.
PriceH. L., LindeH. V., JonesR. E., BlackG. V., and PriceM. L. (1959): “Sympathoadrenal Responses to General Anesthesia in Man and Their Relation to Hemodynamics”, Anesthesiology, 20, 263.
14.
Prys-RobertsC., KelmanG. R., GreenbaumR., KainM. L., and BayJ. (1968): “Hemodynamics and Alveolar-arterial pO2 Differences at Varying pCO2 in Anesthetized Man”, J. Appl. Physiol., 25, 80.
15.
SeveringhausJ., and CullenD. J. (1958): “Depression of Myocardium and Body Oxygen Consumption with Fluothaen”, Anesthesiology, 19, 165.
16.
ShimosatoS., SugaiN., IwatsukiN., and EtstenB. E. (1963): “Ventricular Function During Halothane Anesthesia in Closed Chest Dogs”, Circulation Res., 12, 63.
17.
ShimosatoS., SugaiN., IwatsukiN., and EtstenB. E. (1969): “The Effect of Ethrane on Cardiac Muscle Mechanics”, Anesthesiology, 30, 513.
18.
SmithN. T., EgerE. I.II, WhitcherC. E., StoeltingR. K., and WhayneT. F. (1968): “The Circulatory Effects of the Addition of Nitrous Oxide to Halothane Anaesthesia in Man”, Anesthesiology, 29, 212.
19.
VirtueR. W. (1966): “Difluoromethyl 1, 1, 2–trifluoro–2–chloroethyl Ether as an Anesthetic Agent; Results with Dogs, and a Preliminary Note on Observations with Man”, Canad. Anaesth. Soc. J., 13, 233–241.
